Navigation Links
Millennium Submits sNDA for VELCADE(R) (Bortezomib) for Injection for the Treatment of Front-Line Multiple Myeloma
Date:12/21/2007

s not been studied in mantle cell lymphoma. Acute development or exacerbation of congestive heart failure, and/or new onset of decreased left ventricular ejection fraction has been reported, including reports in patients with few or no risk factors for decreased left ventricular ejection fraction. There have been rare reports of acute diffuse infiltrative pulmonary disease of unknown etiology such as pneumonitis, interstitial pneumonia, lung infiltration and Acute Respiratory Distress Syndrome in patients receiving VELCADE. Some of these events have been fatal. A higher proportion of these events have been reported in Japan. There have been rare reports of Reversible Posterior Leukoencephalopathy Syndrome (RPLS) in patients receiving VELCADE. RPLS is a rare, reversible, neurological disorder which can present with seizure, hypertension, headache, lethargy, confusion, blindness, and other visual and neurological disturbances. VELCADE is associated with thrombocytopenia and neutropenia. There have been reports of gastrointestinal and intracerebral hemorrhage in association with VELCADE. Transfusions may be considered. Complete blood counts (CBC) should be frequently monitored during treatment with VELCADE. Rare cases of acute liver failure have been reported in patients receiving multiple concomitant medications and with serious underlying medical conditions.

Integrated Safety Data: Safety data from phase 2 and 3 studies of single- agent VELCADE 1.3 mg/m2/dose twice weekly for 2 weeks followed by a 10-day rest period in 1163 patients with multiple myeloma (N=1008) and mantle cell lymphoma (N=155) were integrated and tabulated. In these studies, the safety profile of VELCADE was similar in patients with multiple myeloma and mantle cell lymphoma. In the integrated analysis, the most commonly reported adverse events were asthenic conditions (including fatigue, malaise, and weakness) (64%), nausea (55%), diarrhea (52%), constipation (41%), peripheral neuropathy NEC
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Bear Stearns 20th Annual Healthcare Conference to Webcast Millennium Presentation
2. Synova Healthcare to Participate in Womens Health Care in the New Millennium Conference, as Retail Distribution for the Fem-V(R) Test Kit Expands
3. Statement by Bonnie J. Campbell, Former Attorney General of Iowa and Spokesperson for Atlantic Richfield Co., Millennium Holdings, LLC, NL Industries, Inc., and The Sherwin-Williams Company on the Jury Verdict Reached Today in the Thomas (Milwaukee) Case
4. 2007 Credit Suisse Healthcare Conference to Webcast Millennium Presentation
5. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
6. Millennium Biotechnologies Inc. Signs Five Year $20,000,000 Purchase Agreement with Provider Services Inc. of Cleveland, Ohio
7. Millennium Pharmaceuticals Announces Webcast of American Society of Hematology Investor Event
8. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
9. Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA
10. Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate
11. SGX Pharmaceuticals Submits Investigational New Drug Application for SGX523, a Highly Potent, Selective, Orally Bioavailable cMET Inhibitor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... not protest being overcompensated, even when there are ... and Behavior Program have found. , This could ... believed about the inequity of others, researchers said. ... Brain Connectivity . These findings suggest humans, sense ... the interest humans show in others, outcomes is ...
(Date:8/21/2014)... Home Care Assistance of Centennial ... that it has received the Certified – Trusted Provider ... Care Assistance’s commitment to client satisfaction. , “Our goal ... client’s in the South Metro Denver area are receiving ... of Home Care Assistance of Centennial. “Home Care ...
(Date:8/21/2014)... and health authorities need to ensure that experimental drugs ... context of randomized controlled trials, according to a new ... 21 August, 2014]. , Leading bioethicists Professor ... and Dr Annette Rid, of King,s College London, UK, ... to if experimental drugs are to be deployed in ...
(Date:8/21/2014)... CA (PRWEB) August 21, 2014 ... of American Corporate Health, was recently recognized ... influential professionals in the field of workers’ ... National Workers’ Compensation and Occupational Medicine Conference ... including attorneys, physicians, nurses, case managers, disability ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 According to ... "Medical Fiber Optics Market-Global Industry Analysis, Size, Share, Growth, ... fiber optics market was valued at USD 863.1 million ... CAGR of 7.6% from 2013 to 2019, to reach ... , The medical fiber optics market is witnessing significant ...
Breaking Medicine News(10 mins):Health News:Influenced by self-interest, humans less concerned about inequity to others 2Health News:Influenced by self-interest, humans less concerned about inequity to others 3Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 2Health News:Home Care Assistance of Centennial Receives Home Care Pulse Certified – Trusted Provider Distinction 3Health News:The Lancet: Experimental Ebola drugs must be fairly distributed and tested ethically in clinical trials 2Health News:Dr. Vasili Gatsinaris Named One of the Top 50 Most Influential in Workers’ Compensation 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 2Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 3Health News:Global Medical Fiber Optics Market: Industry Analysis, Size, Share, Growth, Trend and Forecast 2013 - 2019 4
... recurrence of breast cancer shows promise in fighting life-threatening ... born prematurely and patients with cancer. Some scientists suspected ... the University of Rochester Medical Center shows that it ... disease. "It,s still early, but if tamoxifen, or ...
... ... to share their experiences and tips on keeping kids healthy and active this summer ... Minneapolis, MN (PRWEB) July 20, ... and television aside as they enjoy the summer sun. While the occasional bump or bruise ...
... , , Stronger ... WASHINGTON, July 20 Five organizations representing the nation,s ... public health and disease prevention announced their support for a provision ... within the healthcare reform bill introduced by leaders of the U.S. ...
... July 20 The following was released today by Randall Terry, founder of Operation ... discussing potential backlash -- including the potential of unwanted violence -- if Congress votes ... Address: National Press Building, 529 14th Street NW, Washington, DC , ... , Leaders to be present: , , ...
... , , ... Competition between employer-based health insurance plans and a government-sponsored public ... the majority of employers responding to a Health Care Reform Survey, ... Aon Corporation (NYSE: AOC ). What will help ...
... , , , ... CareFusion Corporation, the company that will become publicly traded following ... of Cardinal Health, today announced it has expanded its Pyxis((R)) ... (ORIS), incorporate radio-frequency identification (RFID) technology(1) and include new services. ...
Cached Medicine News:Health News:Breast cancer drug shows promise against serious infections 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 2Health News:Treating Kids' Summertime Bumps, Bruises and Injuries with The Healthcare Scoop 3Health News:Experts Support National Public Reporting of Healthcare-Associated Infections 2Health News:Experts Support National Public Reporting of Healthcare-Associated Infections 3Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 2Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 3Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 4Health News:Employers Express Doubts About Employer Mandate and Government-Sponsored Public Plan, Says Aon Consulting Survey 5Health News:CareFusion Expands Pyxis(R) Perioperative Solutions Offering 2Health News:CareFusion Expands Pyxis(R) Perioperative Solutions Offering 3Health News:CareFusion Expands Pyxis(R) Perioperative Solutions Offering 4Health News:CareFusion Expands Pyxis(R) Perioperative Solutions Offering 5
(Date:8/21/2014)...   Royal Philips (NYSE: ... received 510(k) clearance from the U.S. Food and ... for Transcatheter Aortic-Valve Implantation (TAVI) treatments. Through 3D ... pre-procedural, high-precision positioning to treat aortic stenosis ailments.  ... available as part of Philips IntelliSpace Portal ...
(Date:8/20/2014)... 2014 Northstar Global Business Services, Inc., ... of hard work from many talented specialists, the ... and package design.  The new formulation for Snorenz ... the product due to overwhelming evidence of increased ... Nighttime will also include these vitamins, as well ...
(Date:8/20/2014)... 20, 2014  The National Association of Drug ... achieved by the real-time, pseudoephedrine (PSE) blocking system ... Log Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales ... offenders and make arrests. Data released by NPLEx ... blocked the sale of more than 32,890 ...
Breaking Medicine Technology:Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 2Philips receives FDA 510(k) Clearance for TAVI Precision Treatment Planning Application 3Northstar completes the first phase of its new retail strategy and prepares to ship reformulated Snorenz with all new packaging 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... Industries, Inc., a manufacturer of OTC drug products has ... Chief Operating Officer,s (COO) role.   Vize ... and Biotechnology field to H&P mostly with Abbott Laboratories. ... Validations to H&P as they begin to restart their ...
... 2011 Eurotech , a leading supplier of ... been selected to supply embedded computers to ... diagnostics solutions.  The value of the six-month contract is ... The Eurotech Sphere II will allow the customer to ...
Cached Medicine Technology:Eurotech Awarded 1.5M USD Contract to Supply Embedded Computers for Medical Application 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: